External beam radiotherapy is associated with a 10% survival advantage in women with deeply myoinvasive, high-grade endometrial cancer only, but women at lower risk of recurrence do not benefit.

For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve outcomes versus chemotherapy.

As expected, the ovarian cancers looked like human high-grade serous ovarian cancer. "But they also clustered with this form ...

A team of U.S.-based researchers recently examined the results of 2 long-term studies that addressed how different menopausal hormone therapy regimens impact a woman’s risk of developing or ...

Mean growth-hormone (HGH) concentrations during six-hour oral glucose tolerance tests were significantly higher in patients with endometrial carcinoma ... hours were not as high as those ...

In a randomized trial of 427 patients with stage I or II endometrial cancer at high–intermediate risk of recurrence (defined as having two of the following: grade 3 histology, outer half ...